No Available References
- Network Diagnostics: "Default-Mode" Brain Areas Identify Early AD
- Anti-Amyloid Treatment in Asymptomatic AD Trial
- NIH Director Announces $100M Prevention Trial of Genentech Antibody
- A Close Look at Passive Immunotherapy Newbie, Crenezumab
- Colombians Come to Fore in Alzheimer’s Research, Mass Media
- Miami: When Does Amyloid Deposition Start in Familial Alzheimer’s?
- Experimental α7 Agonist Meets Cognitive and Clinical Endpoints
- Q&A With Roche’s CNS Leader Luca Santarelli
- When Is a C9ORF72 Repeat Expansion Not a C9ORF72 Repeat Expansion?
- Wave of New BACE Inhibitors Heading to Phase 2
- Researchers Join to Draw Posterior Cortical Atrophy Out of Shadows
- CSF Markers: Goodbye, Research Use Only; Hello, Clinical
- Cochrane Asks for Field’s Input on Draft Reporting Standards
- Collaborative Umbrella CAPs Three Prevention Trial Initiatives
- DIAN: Registry for eFAD to Chart Alzheimer’s Preclinical Decade
- Reeling In Biomarker Data in Young Carriers, API Rocks Staging Boat
- DIAN Dispatch from Hawaii: Glimpse at Data, Push for Trials
- DIAN Forms Pharma Consortium, Submits Treatment Trial Grant
- DIAN Grows, Gets Ready for Therapeutic Trials
- New Assays for Aβ Oligomers in CSF Claim Femtogram Sensitivity
- Metrology, Certification Heavies Take CSF Tests Under Their Wings
- Can We All Agree on How to Draw a Hippo(campus)?
- On Risk, Benefit, and More, Prevention Initiatives Take Questions